[
    {
        "Sentence": "we may encounter unforeseen expenses , difficulties , complications and delays , and may not be successful in such a transition . we have incurred significant operating losses since inception and anticipate that we will continue to incur substantial operating losses for the foreseeable future and may never achieve or maintain profitability . since our inception , we have incurred significant operating losses .",
        "Positive": 0.010988169349730015,
        "Negative": 0.9681077599525452,
        "Neutral": 0.020904121920466423,
        "Sentiment": "negative",
        "MaxScore": 0.9681077599525452
    },
    {
        "Sentence": "bti has incurred substantial net losses and negative cash flows from operating activities in nearly every fiscal period since inception and expects this trend to continue for the foreseeable future .",
        "Positive": 0.015286607667803764,
        "Negative": 0.9678226709365845,
        "Neutral": 0.01689070463180542,
        "Sentiment": "negative",
        "MaxScore": 0.9678226709365845
    },
    {
        "Sentence": "we expect to continue to incur significant expenses and increasing operating losses for the foreseeable future .",
        "Positive": 0.0173935703933239,
        "Negative": 0.966458797454834,
        "Neutral": 0.016147634014487267,
        "Sentiment": "negative",
        "MaxScore": 0.966458797454834
    },
    {
        "Sentence": "if we fail to comply with the rules under the sarbanes - oxley act related to disclosure controls and procedures in the future , or , if we discover material weaknesses and other deficiencies in our internal control and accounting procedures , our stock price could decline significantly and raising capital could be more difficult .",
        "Positive": 0.009100174531340599,
        "Negative": 0.9654833674430847,
        "Neutral": 0.025416430085897446,
        "Sentiment": "negative",
        "MaxScore": 0.9654833674430847
    },
    {
        "Sentence": "inventory levels in excess of customer demand may result in inventory write - downs or write - offs , which would cause our gross margin to be adversely affected and could impair the strength of our brand .",
        "Positive": 0.00897073745727539,
        "Negative": 0.9627979397773743,
        "Neutral": 0.028231339529156685,
        "Sentiment": "negative",
        "MaxScore": 0.9627979397773743
    },
    {
        "Sentence": "even if we are successful in defending against such claims , litigation could result in substantial costs and be a distraction to management and other employees .",
        "Positive": 0.009903749451041222,
        "Negative": 0.9627647995948792,
        "Neutral": 0.027331408113241196,
        "Sentiment": "negative",
        "MaxScore": 0.9627647995948792
    },
    {
        "Sentence": "if we cannot provide reliable financial reports or prevent fraud , our business and operating results could be harmed , investors could lose confidence in our reported financial information , and the trading price of our common stock could drop significantly . comprehensive tax reform bills could adversely affect our business and financial condition . in 2017 , the u . s .",
        "Positive": 0.007839628495275974,
        "Negative": 0.9626851081848145,
        "Neutral": 0.029475176706910133,
        "Sentiment": "negative",
        "MaxScore": 0.9626851081848145
    },
    {
        "Sentence": "adverse differences between interim data and final data could significantly harm our business prospects .",
        "Positive": 0.010525666177272797,
        "Negative": 0.9624496102333069,
        "Neutral": 0.027024704962968826,
        "Sentiment": "negative",
        "MaxScore": 0.9624496102333069
    },
    {
        "Sentence": "in addition , any delays in completing our clinical trials will increase our costs , slow down our product candidate development and approval process and jeopardize our ability to commence product sales and generate revenues .",
        "Positive": 0.009631909430027008,
        "Negative": 0.9623426198959351,
        "Neutral": 0.028025424107909203,
        "Sentiment": "negative",
        "MaxScore": 0.9623426198959351
    },
    {
        "Sentence": "it is not uncommon for companies in the biopharmaceutical industry to suffer significant setbacks in advanced clinical trials due to nonclinical findings made while clinical studies are underway and safety or efficacy observations made in clinical studies , including previously unreported adverse events .",
        "Positive": 0.01428076159209013,
        "Negative": 0.9612837433815002,
        "Neutral": 0.024435488507151604,
        "Sentiment": "negative",
        "MaxScore": 0.9612837433815002
    },
    {
        "Sentence": "we may also have to take inventory write - offs and incur other charges and expenses for products that fail to meet specifications or pass safety inspections .",
        "Positive": 0.009443430230021477,
        "Negative": 0.9609759449958801,
        "Neutral": 0.029580600559711456,
        "Sentiment": "negative",
        "MaxScore": 0.9609759449958801
    },
    {
        "Sentence": "furthermore , if one or more of the analysts who do cover us downgrade our stock or if those analysts issue other unfavorable commentary about us or our business , our stock price would likely decline .",
        "Positive": 0.011410443112254143,
        "Negative": 0.959549069404602,
        "Neutral": 0.02904045209288597,
        "Sentiment": "negative",
        "MaxScore": 0.959549069404602
    },
    {
        "Sentence": "conversely , if we underestimate customer demand for igalmi , our third - party contract manufacturer may not be able to deliver products to meet our requirements , and this could result in damage to our reputation and customer relationships .",
        "Positive": 0.011220455169677734,
        "Negative": 0.9578532576560974,
        "Neutral": 0.030926207080483437,
        "Sentiment": "negative",
        "MaxScore": 0.9578532576560974
    },
    {
        "Sentence": "future changes in corporate tax rates , the realization of net deferred tax assets relating to our operations , the taxation of any foreign earnings , and the deductibility of expenses under future reform legislation could have a material impact on the value of our deferred tax assets , could result in significant one - time charges , and could increase our future u . s .",
        "Positive": 0.01195473037660122,
        "Negative": 0.9576241970062256,
        "Neutral": 0.03042111173272133,
        "Sentiment": "negative",
        "MaxScore": 0.9576241970062256
    },
    {
        "Sentence": "we incurred losses of $ 52 , 796 and $ 31 , 472 for the three months ended 45table of contentsmarch 31 , 2023 and 2022 , respectively .",
        "Positive": 0.01314218807965517,
        "Negative": 0.9575892090797424,
        "Neutral": 0.02926858700811863,
        "Sentiment": "negative",
        "MaxScore": 0.9575892090797424
    },
    {
        "Sentence": "from time to time , there may be 85table of contentschanges in our executive management and leadership teams resulting from the hiring or departure of executives or other key employees , which could disrupt our business .",
        "Positive": 0.007516918238252401,
        "Negative": 0.9567049145698547,
        "Neutral": 0.035778194665908813,
        "Sentiment": "negative",
        "MaxScore": 0.9567049145698547
    },
    {
        "Sentence": "are expensive and time - consuming , and our management is required to devote substantial time to compliance matters . as a publicly traded company we have incurred and will continue to incur significant legal , accounting and other expenses .",
        "Positive": 0.011110367253422737,
        "Negative": 0.9541032910346985,
        "Neutral": 0.03478631377220154,
        "Sentiment": "negative",
        "MaxScore": 0.9541032910346985
    },
    {
        "Sentence": "in addition to continuing pressure on prices and cost containment measures , legislative developments at the eu or member state level may result in significant additional requirements or obstacles that may increase our operating costs .",
        "Positive": 0.025338171049952507,
        "Negative": 0.9535686373710632,
        "Neutral": 0.021093158051371574,
        "Sentiment": "negative",
        "MaxScore": 0.9535686373710632
    },
    {
        "Sentence": "this relocation has caused , and may continue to cause , disruption in the administrative and medical scientific links between the ema and the mhra , including delays in granting clinical trial authorization or ma , disruption of importation and export of active substance and other components of new drug formulations , and disruption of the supply chain for clinical trial product and final authorized formulations .",
        "Positive": 0.007976171560585499,
        "Negative": 0.953392744064331,
        "Neutral": 0.03863103315234184,
        "Sentiment": "negative",
        "MaxScore": 0.953392744064331
    },
    {
        "Sentence": "if we are required by the fda , or other regulatory authorities such as the european medicines agency ( & # 8220 ; ema & # 8221 ; ) to perform studies and trials in addition to those currently expected , or if there are any delays in the development , or in the completion of any planned or future preclinical studies or clinical trials of our current or future product candidates , our expenses could increase and profitability could be further delayed . even if we do achieve profitability , we may not be able to sustain or increase profitability on a quarterly or annual basis . our failure to become and remain profitable would decrease the value of our company and could impair our ability to raise capital , maintain our research and development efforts , expand our business or continue our operations .",
        "Positive": 0.012145553715527058,
        "Negative": 0.9524281620979309,
        "Neutral": 0.0354263000190258,
        "Sentiment": "negative",
        "MaxScore": 0.9524281620979309
    }
]